| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |